374 related articles for article (PubMed ID: 12601443)
1. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
[TBL] [Abstract][Full Text] [Related]
2. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
Mittmann N; Knowles S
Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
[TBL] [Abstract][Full Text] [Related]
3. A survey of selective administration procedures in formulary maintenance.
Quigley MA; Brown WM
Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
[TBL] [Abstract][Full Text] [Related]
4. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
[TBL] [Abstract][Full Text] [Related]
5. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
Segal R; Pathak DS
Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
[TBL] [Abstract][Full Text] [Related]
6. P & T Committee interview: strategies to ensure an effective formulary system.
Riff L; Hutchinson R
Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
[TBL] [Abstract][Full Text] [Related]
7. Survey of formulary system policies and procedures.
Rascati KL
Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
[TBL] [Abstract][Full Text] [Related]
8. Developing an effective P & T Committee, Part 2.
Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
[TBL] [Abstract][Full Text] [Related]
9. Diffusion of innovation II: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a drug development perspective.
D'Sa MM; Hill DS; Stratton TP
Can J Hosp Pharm; 1995 Feb; 48(1):7-15. PubMed ID: 10141063
[TBL] [Abstract][Full Text] [Related]
10. The formulary decision-making process in a US academic medical centre.
Nash DB; Catalano ML; Wordell CJ
Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
[TBL] [Abstract][Full Text] [Related]
11. Use of pharmacoeconomic data in making hospital formulary decisions.
Odedina FT; Sullivan J; Nash R; Clemmons CD
Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
[TBL] [Abstract][Full Text] [Related]
12. Diffusion of innovation I: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a hospital pharmacy perspective.
D'Sa MM; Hill DS; Stratton TP
Can J Hosp Pharm; 1994 Dec; 47(6):254-60. PubMed ID: 10139270
[TBL] [Abstract][Full Text] [Related]
13. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
Kile DM; McGrath ME; Schindel LP
Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
[TBL] [Abstract][Full Text] [Related]
14. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
[TBL] [Abstract][Full Text] [Related]
15. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
Penm J; Chaar B; Dechun J; Moles R
Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
Skaer TL
Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
[TBL] [Abstract][Full Text] [Related]
17. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
Weekes LM; Day RO
Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
[TBL] [Abstract][Full Text] [Related]
18. Formulary management at a tertiary-care facility: P&T committee interview.
Lucas RV; Abramowitz PW
Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
[TBL] [Abstract][Full Text] [Related]
19. INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
Int J Technol Assess Health Care; 2016 Jan; 32(1-2):81-7. PubMed ID: 27001376
[TBL] [Abstract][Full Text] [Related]
20. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
Conolly ME
Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
